Edition:
India

Laurus Labs Ltd (LAUL.NS)

LAUL.NS on National Stock Exchange of India

1,468.90INR
9:46am IST
Change (% chg)

Rs47.95 (+3.37%)
Prev Close
Rs1,420.95
Open
Rs1,444.95
Day's High
Rs1,495.00
Day's Low
Rs1,444.45
Volume
302,055
Avg. Vol
1,738,790
52-wk High
Rs1,550.00
52-wk Low
Rs295.00

Latest Key Developments (Source: Significant Developments)

Laurus Labs Gets U.S. FDA Approvals For Two ANDAs
Tuesday, 19 May 2020 

May 19 (Reuters) - Laurus Labs Ltd ::RECEIVES USFDA APPROVALS FOR ANDAS TLE 400 AND TLE 600 TABLETS.  Full Article

India's Laurus Labs Approves For Payment Of Interim Dividend Of 1.50 Rupees/Share
Thursday, 12 Mar 2020 

March 12 (Reuters) - Laurus Labs Ltd ::APPROVED FOR PAYMENT OF INTERIM DIVIDEND OF 1.50 RUPEES/SHARE FOR FY 2019-20.  Full Article

Laurus Labs Says Confident Of Achieving Positive Free Cashflows Status From FY21 Onwards
Thursday, 30 Jan 2020 

Jan 30 (Reuters) - Laurus Labs Ltd ::LAURUS LABS LTD - REMAIN CONFIDENT OF ACHIEVING POSITIVE FREE CASHFLOWS STATUS FROM FY21 ONWARDS.  Full Article

India's Laurus Labs Dec Qtr Consol Net PAT Rises
Thursday, 30 Jan 2020 

Jan 30 (Reuters) - Laurus Labs Ltd ::DEC QUARTER CONSOL NET PAT 734.8 MILLION RUPEES VERSUS 178.2 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 7.3 BILLION RUPEES VERSUS 5.29 BILLION RUPEES YEAR AGO.  Full Article

India's Laurus Labs Says US FDA Finds 3 Observations After Vizag Plant Inspection
Thursday, 21 Nov 2019 

Nov 21 (Reuters) - Laurus Labs Ltd ::COMPLETES US FDA, PRE-APPROVAL INSPECTION (PAI), FOR AN API MANUFACTURED AT ITS UNITS 1&3, VISAKHAPATNAM.FDA INSPECTION FOUND 3 OBSERVATIONS.  Full Article

Laurus Labs Ltd Announces Completion Of USFDA Inspection
Friday, 8 Nov 2019 

Nov 8 (Reuters) - Laurus Labs Ltd ::LAURUS LABS LTD SAYS USFDA INSPECTION OF ITS FDF & API INTEGRATED FACILITY, UNIT 2 AT VISAKHAPATNAM HAS BEEN COMPLETED.LAURUS LABS LTD SAYS INSPECTION WAS CARRIED OUT FROM NOV 4 TO NOV 8.LAURUS LABS LTD SAYS NO DATA INTEGRITY ISSUES WERE OBSERVED IN THE INSPECTION..  Full Article

India's Laurus Labs Sept-Quarter Net Profit Rises
Thursday, 31 Oct 2019 

Oct 31 (Reuters) - Laurus Labs Ltd ::SEPT-QUARTER NET PROFIT 565.5 MILLION RUPEES VERSUS 162.1 MILLION RUPEES YEAR AGO.SEPT-QUARTER REVENUE FROM OPERATIONS 7.12 BILLION RUPEES VERSUS 5.88 BILLION RUPEES YEAR AGO.  Full Article

Laurus Labs Gets Establishment Inspection Report From US FDA For Parawada API Units
Thursday, 5 Sep 2019 

Sept 5 (Reuters) - Laurus Labs Ltd ::GETS ESTABLISHMENT INSPECTION REPORT FROM US FDA FOR API UNITS AT PARAWADA, VISAKHAPATNAM, FOR INSPECTION CONDUCTED IN JUNE 2019.IN FDF SEGMENT, GETS GLOBAL FUND EXPERT REVIEW PANEL APPROVAL FOR FIXED DOSE COMBINATION TLE 400 FOR SUPPLY IN GF FUNDED PROJECTS.  Full Article

India's Laurus Labs June-Qtr Profit Falls
Friday, 2 Aug 2019 

Aug 2 (Reuters) - Laurus Labs Ltd ::JUNE QUARTER NET PAT 150.6 MILLION RUPEES VERSUS 165.6 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 5.50 BILLION RUPEES VERSUS 5.39 BILLION RUPEES YEAR AGO.  Full Article

Laurus Labs Completes USFDA Inspection Of Visakhapatnam Unit Without Observations, No Form 483 Issued
Friday, 12 Jul 2019 

July 12 (Reuters) - Laurus Labs Ltd ::COMPLETED USFDA INSPECTION OF UNIT 4 AT VISAKHAPATNAM, ANDHRA PRADESH, WITHOUT ANY OBSERVATIONS AND NO FORM 483 ISSUED.  Full Article

CARE ratings for Indian debt instruments-Jul 1

Jul 1 - Below are the ratings awarded by Credit Analysis and Research Ltd. (CARE) for local debt instruments as of June 30, 2020. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------- ---------- ------ ------- --------- SHORT TERM RATINGS: ------------------- Aradhan Chemtech ST BkFac CARE A4;